Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Death Dis ; 14(5): 343, 2023 05 29.
Artículo en Inglés | MEDLINE | ID: mdl-37248211

RESUMEN

Astrocyte atrophy is the main histopathological hallmark of major depressive disorder (MDD) in humans and in animal models of depression. Here we show that electroacupuncture prevents astrocyte atrophy in the prefrontal cortex and alleviates depressive-like behaviour in mice subjected to chronic unpredictable mild stress (CUMS). Treatment of mice with CUMS induced depressive-like phenotypes as confirmed by sucrose preference test, tail suspension test, and forced swimming test. These behavioural changes were paralleled with morphological atrophy of astrocytes in the prefrontal cortex, revealed by analysis of 3D reconstructions of confocal Z-stack images of mCherry expressing astrocytes. This morphological atrophy was accompanied by a decrease in the expression of cytoskeletal linker Ezrin, associated with formation of astrocytic leaflets, which form astroglial synaptic cradle. Electroacupuncture at the acupoint ST36, as well as treatment with anti-depressant fluoxetine, prevented depressive-like behaviours, astrocytic atrophy, and down-regulation of astrocytic ezrin. In conclusion, our data further strengthen the notion of a primary role of astrocytic atrophy in depression and reveal astrocytes as cellular target for electroacupuncture in treatment of depressive disorders.


Asunto(s)
Trastorno Depresivo Mayor , Electroacupuntura , Humanos , Ratones , Animales , Depresión/terapia , Depresión/metabolismo , Antidepresivos/metabolismo , Astrocitos/metabolismo , Trastorno Depresivo Mayor/tratamiento farmacológico , Hipocampo/metabolismo , Atrofia/tratamiento farmacológico , Atrofia/metabolismo , Atrofia/patología , Modelos Animales de Enfermedad
2.
Prog Biophys Mol Biol ; 87(1): 33-46, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15471589

RESUMEN

Although GABA(A) receptors are widely distributed at inhibitory synapses on dendrites and cell bodies of neurons, they also occur in other places, in particular at synapses made on axons and in extrasynaptic membranes. This review summarises some of the evidence that presynaptic receptors modulate transmission not only at primary afferents in the spinal cord, but also at a variety of sites in the brain, including hippocampal mossy fibres. These receptors modulate transmitter release via several different mechanisms. Another form of unconventional GABA(A) receptor-mediated signalling is the mediation of a tonic conductance, seen in granule cells of the cerebellum and dentate gyrus and also in hippocampal interneurons. Tonic signalling appears to be mediated by extrasynaptic receptors. The adaptive significance of this form of signalling remains poorly understood.


Asunto(s)
Sistema Nervioso Central/metabolismo , Receptores de GABA-A/metabolismo , Adaptación Fisiológica , Vías Aferentes/metabolismo , Animales , Axones/metabolismo , Señalización del Calcio , Cerebelo/metabolismo , Giro Dentado/metabolismo , Humanos , Fibras Musgosas del Hipocampo/metabolismo , Receptores Presinapticos/metabolismo , Transducción de Señal , Transmisión Sináptica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA